Commodore Capital as of Sept. 30, 2022
Portfolio Holdings for Commodore Capital
Commodore Capital holds 30 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cogent Biosciences (COGT) | 10.4 | $65M | 4.3M | 14.92 | |
| Xenon Pharmaceuticals (XENE) | 9.3 | $58M | 1.6M | 36.10 | |
| Miragen Therapeutics (VRDN) | 8.9 | $55M | 2.7M | 20.51 | |
| Bellus Health Com New | 8.7 | $54M | 5.1M | 10.56 | |
| Merus N V (MRUS) | 8.4 | $52M | 2.6M | 20.03 | |
| Cytokinetics Com New (CYTK) | 7.0 | $43M | 894k | 48.45 | |
| Aclaris Therapeutics (ACRS) | 6.1 | $38M | 2.4M | 15.74 | |
| Akero Therapeutics (AKRO) | 4.1 | $25M | 744k | 34.05 | |
| Satsuma Pharmaceuticals Ord | 3.6 | $22M | 3.7M | 6.00 | |
| Tricida | 3.3 | $21M | 2.0M | 10.48 | |
| Cymabay Therapeutics | 3.2 | $20M | 5.7M | 3.50 | |
| Third Harmonic Bio (THRD) | 3.1 | $19M | 1.0M | 18.97 | |
| Syndax Pharmaceuticals (SNDX) | 2.9 | $18M | 738k | 24.03 | |
| Celldex Therapeutics Com New (CLDX) | 2.4 | $15M | 539k | 28.11 | |
| Day One Biopharmaceuticals I (DAWN) | 2.4 | $15M | 740k | 20.03 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.1 | $13M | 404k | 33.05 | |
| Kura Oncology (KURA) | 2.0 | $12M | 899k | 13.66 | |
| Acumen Pharmaceuticals (ABOS) | 1.8 | $11M | 1.1M | 10.03 | |
| Karyopharm Therapeutics (KPTI) | 1.7 | $11M | 1.9M | 5.46 | |
| Allakos (ALLK) | 1.6 | $10M | 1.6M | 6.12 | |
| Alpine Immune Sciences (ALPN) | 1.5 | $9.5M | 1.3M | 7.20 | |
| Celcuity (CELC) | 1.5 | $9.2M | 921k | 10.04 | |
| Enanta Pharmaceuticals (ENTA) | 0.9 | $5.4M | 104k | 51.87 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $4.5M | 313k | 14.51 | |
| Rezolute Com New (RZLT) | 0.5 | $3.3M | 1.2M | 2.74 | |
| Esperion Therapeutics (ESPR) | 0.5 | $3.1M | 468k | 6.70 | |
| Immunic (IMUX) | 0.5 | $2.8M | 893k | 3.16 | |
| Bcls Acquisition Corp Com Cl A | 0.4 | $2.5M | 250k | 10.02 | |
| Larimar Therapeutics (LRMR) | 0.4 | $2.4M | 750k | 3.20 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $1.2M | 206k | 5.89 |
